Caesars Entertainment M&A Deal with Fertitta Gaming Holdco, LLC
Caesars Entertainment provided a status update on its pending merger with Fertitta Gaming Holdco, LLC, specifically addressing a stockholder demand letter alleging disclosure omissions in the proxy statement. To avoid potential delays to the merger timeline, the company issued supplemental disclosures regarding its legal counsel's unrelated work for Tilman J. Fertitta's affiliates.
XFLH Capital Corporation, a SPAC, has signed a non-binding letter of intent for a business combination with Renogen Biolab Inc., a Canadian health service provider specializing in molecular capabilities such as DNA services and vector engineering. The parties are now working to negotiate definitive agreements and conduct mutual due diligence to finalize the merger.
Iron Horse Acquisition II Signs $250M M&A Deal with Electra Vehicles, Inc.
Iron Horse Acquisition II Corp. (IRHO) provided a status update on its pending merger with Electra Vehicles, Inc., a transaction valued at over $250 million. The update highlights commercial milestones achieved since the April 2026 agreement, including new partnerships with Mooving, Omega Seiki Mobility, and Propel Industries, as the companies work toward a closing in the second half of 2026.
Beam Global M&A Deal with Unnamed European drone technology company
Beam Global has signed a non-binding letter of intent to acquire a European drone technology company that develops AI-enhanced software and hardware. If completed, Beam intends to manufacture the target's U.S. Department of War conditionally approved drone systems in its existing U.S. and European factories. The deal aims to transform Beam into a vertically integrated drone and software provider, leveraging its existing battery manufacturing expertise and government customer base.
Lexeo Therapeutics Signs $8.3M M&A Deal with Mantle Therapeutics Inc.
Lexeo Therapeutics entered into a definitive agreement to acquire Mantle Therapeutics for an upfront purchase price of $5.3 million in cash and $3.0 million in common stock. The deal includes up to $12.0 million in contingent development and regulatory milestone payments plus a $1.0 million cash payment upon specific events, aimed at expanding Lexeo's Friedreich ataxia (FA) pipeline with new CNS-targeted modalities.
Ligand Pharmaceuticals Signs $23M M&A Deal with Sydnexis, Inc.
Ligand Pharmaceuticals acquired royalty and milestone payment rights for Ryjunea from Sydnexis for $23 million upfront. Ryjunea is a treatment for pediatric myopia licensed to Santen Pharmaceutical in the EMEA region, where it is already approved. Ligand will receive tiered royalties ranging from low-double-digits to high-teens on net sales in those territories.
Cognex Corporation has entered into a definitive agreement to acquire RealSense, Inc., a leader in 3D depth-sensing cameras and robotic perception technology, for $500 million in cash. The deal expands Cognex's presence in the high-growth robotic perception and Physical AI markets and is expected to close in the fourth quarter of 2026. Cognex will also implement retention packages for RealSense employees consisting of approximately $50 million in RSUs and up to $69 million in cash payments over three years.
Value
$500M
Counterparty
RealSense, Inc.
Earnings call
Sep 22, 2026, 8:00 AM ET
“RealSense represents a compelling strategic expansion for Cognex into robotic perception, one of the most attractive adjacent markets in machine vision. RealSense brings a leading 3D perception platform with proprietary technology, a strong developer community and a compelling value proposition for customers. Combined with Cognex’s machine vision expertise and global reach, RealSense positions us to offer a full-stack visual intelligence platform, spanning industrial ID, 2D and 3D machine vision measurement to 3D depth perception and robotic navigation, built to serve the full spectrum of Physical AI.”
Matt Moschner, President and Chief Executive Officer of Cognex
“RealSense was built on a simple idea: robots and autonomous systems can’t act intelligently in the physical world if they can’t first perceive it accurately. We’ve called that mission the Visual Cortex of Physical AI. Joining Cognex puts that mission on an entirely new scale, giving us access to a global industrial customer base and go-to-market reach that would have taken us years to build on our own. This is a combination that makes both businesses stronger.”
Nadav Orbach, Chief Executive Officer of RealSense
Blue Acquisition M&A Deal with Blockfusion USA, Inc.
Blue Acquisition Corp. entered into a sixth amendment to its definitive business combination agreement with Blockfusion USA, Inc. to revise the deal structure. The amendment increases the maximum earnout shares to 15 million based on stock price thresholds of $13, $15, and $17, and adjusts the treatment of a warrant held by CoreWeave, Inc. to be exchanged for Pubco shares upon closing.
Vista Gold Signs $427M M&A Deal with Artemis Gold Inc.
Vista Gold Corp. has entered into a definitive agreement to be acquired by Artemis Gold Inc. in an all-stock transaction valued at approximately $427 million. Vista shareholders will receive 0.0966 Artemis shares for each Vista share, representing a 29% premium, to gain control of the Mt Todd gold project in Australia.
Algorhythm Holdings Signs $23M M&A Deal with Azure Energy, LLC
Algorhythm Holdings acquired substantially all assets of Azure Energy, LLC for $23 million in stock, marking a strategic pivot into renewable energy infrastructure. The deal includes inventory, intellectual property, and real property related to converting waste and biomass into clean power. In connection with the acquisition, the company dismissed long-time CEO Gary Atkinson as part of a broader leadership and board transition.
IB Acquisition Signs $50M M&A Deal with GNQ Insilico, Inc.
IB Acquisition Corp. entered into a $50 million equity purchase facility with an institutional investor to provide capital following its pending business combination with GNQ Insilico, Inc. The facility allows the company to sell shares of Class A common stock over a 36-month period to support the post-merger entity, which will trade under the symbol GNQI.
Axos Financial Signs $1.9B M&A Deal with Capital One, National Association
Axos Bank, a subsidiary of Axos Financial, Inc., completed its acquisition of approximately $1.9 billion in individual retirement account (IRA) deposits from Capital One. The transaction was finalized under a previously announced Purchase and Assumption Agreement, with Axos receiving cash for the aggregate deposit balance less a negotiated premium.
Tomi Environmental Solutions M&A Deal with Carbonium Core, Inc.
TOMI Environmental Solutions and Carbonium Core have mutually agreed to terminate their previously announced merger agreement originally signed on June 28, 2026. The termination follows additional due diligence regarding Carbonium's business operations and financial performance, with neither party required to pay a termination fee.
Weave Communications M&A Deal with Francisco Partners Management, L.P.
Weave Communications received early termination of the HSR Act waiting period for its pending acquisition by affiliates of Francisco Partners. This regulatory milestone satisfies a key closing condition for the merger, which was originally announced on August 18, 2026. The transaction is currently expected to close in the fourth quarter of 2026, subject to stockholder approval.
Construction Partners M&A Deal with Roads, Inc. of NWF
Construction Partners, Inc. (CPI) has completed the acquisition of Roads, Inc. of NWF, an asphalt manufacturing and construction business based in Cantonment, Florida. The deal includes a hot-mix asphalt plant north of Pensacola and adds more than 150 employees to CPI's Florida platform, C.W. Roberts Contracting. The acquisition is intended to expand the company's service capabilities and geographic footprint in the Florida Panhandle.
PTC Therapeutics M&A Deal with Sangamo Therapeutics, Inc.
PTC Therapeutics has completed its acquisition of ST-920 (isaralgagene civaparvovec), a BLA-stage AAV gene therapy for Fabry disease, from Sangamo Therapeutics. The company expects to complete a rolling Biologics License Application (BLA) submission to the FDA for accelerated approval in the fourth quarter of 2026. The acquisition adds a potential one-time treatment for Fabry disease to PTC's rare disorder pipeline.
Calisa Acquisition M&A Deal with Goodvision AI Inc.
Calisa Acquisition Corp entered into a Prepaid Forward Purchase Agreement with Goodvision AI Inc. and Harraden Circle Investments to support its pending business combination. Under the agreement, the purchaser may acquire up to 3,000,000 ordinary shares to minimize redemptions and maximize cash retention upon the closing of the merger.
Isabella Bank M&A Deal with Grand River Commerce, Inc.
Isabella Bank Corporation announced that shareholders of Grand River Commerce, Inc. have approved the previously announced merger agreement between the two companies. The transaction, which involves the merger of Grand River into Isabella and their respective bank subsidiaries, is expected to close in the fourth quarter of 2026 subject to regulatory approvals.
Bunker Hill Mining M&A Deal with Silver47 Exploration Corp.
Bunker Hill Mining Corp. is providing a status update on its pending acquisition of Silver47 Exploration Corp. by filing historical and pro forma financial statements required for the transaction. The filing includes audited financials for Silver47 and Summa Silver Corp. to facilitate the incorporation of the deal into the company's registration statements.
TransDigm Group Signs $240M M&A Deal with Extant Aerospace / Portfolio of commercial rotorcraft
TransDigm Group's operating unit, Extant Aerospace, has entered into a definitive agreement to acquire a portfolio of commercial rotorcraft, land systems, and business jet products, including a California facility, for approximately $240 million in cash. The acquisition is expected to close during fiscal year 2027, subject to regulatory approvals and customary closing conditions.
Value
$240M
Counterparty
Extant Aerospace (operating unit) / Portfolio of commercial rotorcraft, land systems, and business jet products
Lantheus Holdings M&A Deal with Curium US Holdings LLC
Lantheus Holdings provided a regulatory update on its pending merger with Curium US Holdings LLC, noting that Curium voluntarily withdrew and refiled its HSR Act pre-merger notification to provide the FTC with additional time for review. The new 30-day waiting period is set to expire on October 21, 2026, and the parties still expect to close the transaction in the first half of 2027.
Insight Molecular Diagnostics M&A Deal with Chronix Biomedical, Inc.
Insight Molecular Diagnostics (iMDx) entered into Amendment No. 2 to its merger agreement with Chronix, modifying the earnout structure related to the CNI Monitor technology. The amendment establishes that equity holders will receive a 10% royalty on sales until a potential sale of the technology occurs, at which point they will receive a final payment of 10% of the gross sale proceeds.
Dick's Sporting Goods Signs $2.5B M&A Deal with Foot Locker, Inc.
DICK’S Sporting Goods filed pro forma financial information regarding its completed acquisition of Foot Locker, Inc. for approximately $2.5 billion. The deal consideration consisted of $0.2 billion in cash and 9.6 million shares of DICK’S common stock, alongside a $381.9 million debt exchange offer for Foot Locker's senior notes.
Inflection Point Acquisition Corp. VII M&A Deal with Elroy Air, Inc.
Inflection Point Acquisition Corp. VII (IPXG) provided a status update on its pending merger with Elroy Air, Inc., an autonomous aircraft developer. The company held a virtual analyst day on September 21, 2026, and filed an updated investor presentation detailing the strategic rationale for the business combination.
National CineMedia Signs $275M M&A Deal with Captivate Holdings, LLC and Captivate Network Holdings, Inc.
National CineMedia completed its acquisition of Captivate, a leading operator of office and residential digital video advertising, for an enterprise value of $275 million. The deal was financed through a new $275 million senior secured term loan and a $25 million revolving credit facility provided by Crestline Direct Finance. The acquisition expands NCM's advertising platform to over 48,000 screens across 185 Designated Market Areas.
Value
$275M
Counterparty
Captivate Holdings, LLC and Captivate Network Holdings, Inc.
Priority Technology Holdings Signs $1.6B M&A Deal with WD Capital Partners Parent Inc.
Priority Technology Holdings, Inc. has entered into a definitive merger agreement to be acquired and taken private by an investor group led by its Chairman and CEO, Thomas Priore, for $8.05 per share in cash. The all-cash transaction represents an enterprise value of approximately $1.6 billion and a 65% premium to the company's unaffected share price. Upon completion, Priority will become a privately held company and a wholly owned subsidiary of WD Capital Partners Parent Inc.
Theravance Biopharma shareholders approved the company's acquisition by Zymeworks Inc. at an extraordinary general meeting. Under the terms of the merger agreement, Theravance will become a wholly owned subsidiary of Zymeworks. The approval included the merger plan, the contingent value rights agreement, and related corporate restructuring.
Medalist Diversified Signs $5.4M M&A Deal with NPH Ventures, LLC
Medalist Diversified, Inc. completed the acquisition of a Caliber Collision Center property in Aubrey, Texas, for a total purchase price of approximately $5.4 million. The acquisition was funded with cash on hand and executed through a Delaware statutory trust (DST). The company intends to offer beneficial interests in the DST to accredited investors via a private placement to redeem its own interests for cash.
ChampionsGate Acquisition Signs $80M M&A Deal with Futuremain Co., Ltd.
ChampionsGate Acquisition Corporation (SPAC) has entered into a definitive business combination agreement to merge with Futuremain Co., Ltd., a Korean company. The transaction values Futuremain at an aggregate closing consideration of $80 million, payable in newly issued ordinary shares of a new public holding company (Pubco) at a deemed value of $10.00 per share. Upon closing, the combined entity is expected to be listed on the Nasdaq Stock Market.
Iridium Communications M&A Deal with Rocket Lab Corporation
Iridium Communications provided a status update on its pending merger with Rocket Lab Corporation, announcing that the special meeting of stockholders to approve the deal is scheduled for September 24, 2026. The company expects the transaction to close in mid-2027, subject to stockholder approval and other closing conditions. The filing also addresses several lawsuits filed by purported stockholders alleging disclosure deficiencies in the proxy statement.